Trade APVO stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Aptevo Therapeutics Inc. (APVO) is trading at US$1.81, up 0.28% today as of Oct 9, 12:29 EDT. The company has a market capitalisation of US$4.83M. Over the past 52 weeks, APVO has traded between US$1.37 and US$31.14. On Syfe you can trade APVO with $0 commission and add it to your watchlist.
| Previous close | US$1.80 |
|---|---|
| Market cap | US$4.83M |
| 52-week range | US$1.37 – US$31.14 |
| Volume | 26.72K |
| Exchange | US |
Aptevo Therapeutics Inc.
Aptevo Therapeutics, Inc. is a clinical-stage biotechnology company, which engages on developing novel immunotherapies for the treatment of cancer. Its pipeline APVO436, ALG.APV-527, and APVO603 were developed based on the ADAPTIR modular protein platform technology and APVO442 was developed based on the new ADAPTIR-FLE platform technology. The ADAPTIR and ADAPTIR-FLEX are capable of generating differentiated bispecific and multi-specific antibodies with potentially unique mechanisms of action for the treatment of different types of cancer. The company was founded in February 2016 and is headquartered in Seattle, WA.
Year: 2016
Aptevo Therapeutics Inc. (APVO) stock is trading at US$1.81, +0.28% from the previous close of US$1.80.
The market cap for Aptevo Therapeutics Inc. (APVO) stock is approximately US$4.83M.
The 52-week high for Aptevo Therapeutics Inc. (APVO) stock is US$31.14.
The 52-week low for Aptevo Therapeutics Inc. (APVO) stock is US$1.37.
Aptevo Therapeutics Inc. (APVO) does not currently pay a dividend.
Stay on top of APVO
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
Popular Stocks in Singapore
